Denis-Rodríguez E, Hermida-Moreno A

Language: Spanish
References: 30
Page: 53-59
PDF size: 375.28 Kb.

ABSTRACT

Amphetamines are included among the drugs of abuse most frequently used; 3,4-methylenedioxymethamphetamine (MDMA), commonly named "ecstasy", is used by millions of people worldwide; rapid detection methods are usually performed on blood samples and urine; the use of oral fluid as a biological substrate provides advantages over other substrates in terms of ease of sampling without adulteration. In this review we analyze the existing evidence about the methodological techniques used in the oral fluid detection of MDMA and the field of application.

REFERENCES

1. Armenta S, Garriques S, de la Guardia M (2015). Analysis of ecstasy in oral fluid by ion mobility spectrometry and infrared spectroscopy after liquid-liquid extraction. J Chromatogr A, 1384, 1-8.

2. Anizan S, Huestis, MA (2014). The potential role of oral fluid in antidoping testing. Clin Chem, 60(2): 307-22.

3. Aps JK, Martens LC (2005) Review: the physiology of saliva and transfer of drugs into saliva. Forensic Sci Int ,150:119–31

4. Barnes AJ, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Ther Drug Monit 2011; 33:602–8

5. Castaneto MS, Barnes AJ (2013). Identifying metamphetamine exposure in children. Ther Drug Monit, 35(6): 823-30.

6. Drummer OH (2006). Drug testing in oral fluid. Clinical and Biochemical Reviews. 27:147–59

7. Drummer OH (2008). Introduction and review of collection techniques and applications of drug testing of oral fluid. Therapeutic Drug Monitoring; 30:203–206.

8. Desrosiers NA, Barnes AJ, Hartman RL (2013). Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration. Anal Bioanal Chem, 405(12): 4067-76.

9. Davey J, Armstrong K, Martin P (2014). Results of the Queensland 2007-2012 roadside drug testing program: The prevalence of three illicit drugs. Accid Anal Prev, 65: 11-17.

10. Farre M, de la Torre R, Mathuna BO (2004). Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology; 173:364–75.

11. Green AR, Mechan AO, Elliott JM (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) Pharmacol Rev. 55:463–508

12. Kraemer T, Maurer HH (2002). Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. Therapeutic Drug Monitoring; 24:277–289

13. Kolbrich EA, Goodwin RS, Gorelick DA (2008). Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Therapeutic drug monitoring; 30:320–32

14. Langel K, Engblom C, Pehrsson A (2008). Drug testing in oral fluid-evaluation of sample collection devices. J Anal Toxicol 2008; 32:393–401.

15. Langel K, Gierde H, Favretto D (2014). Comparison of drug concentrations between whole blood and oral fluid. Drug Test Anal, 6(5): 461-71.

16. Liu HC, Lee HT, Hsu YC (2015). Direct Injection LC-MS-MS Analysis of Opiates, Methamphetamine, Buprenorphine, Methadone and Their Metabolites in Oral Fluid from Substitution Therapy Patients. J Anal Toxicol, epub ahead of print.

17. Lund HM, Oiestad EL, Gjerde H (2011). Drugs of abuse in oral fluid collected by two different sample kits: stability testing and validation using ultra performance tandem mass spectrometry analysis. J Chromatogr B Analyt Technol Biomed Life Sci; 879:3367–77

18. Montesano C, Simeoni MC, Curini R (2015). Determination of illicit drugs and metabolites in oral fluid by microextraction on packed sorbent coupled with LC-MS/MS. Anal Bioanal Chem, 407(13): 3647-58.

19. Navarro M, Pichini S, Farre Ml (2001). Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clinical Chemistry; 47:1788–1795.

20. Nieddu M, Burrai L, Trignano C (2014). Evaluation of commercial multi- drug oral fluid devices to identify 39 new amphetamine-designer drugs. Leg Med, 16(2): 106-9.

21. Peters FT, Samyn N, Kraemer T (2007). Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases. Clin Chem, 53(4):702-10.

22. Samyn N, De Boeck G, Wood M (2002). Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Science International; 128:90–97.

23. Samyn N, Laloup M, De Boeck G (2007). Bioanalytical procedures for determination of drugs of abuse in oral fluid. Anal Bioanal Chem; 388:1437–53

24. Scheidweiler KB, Huestis MA (2006). A validated gas chromatographic-electron impact ionization mass spectrometric method for MDMA, methamphetamine and metabolites in oral fluid. Journal of Chromatography B835:90–99.

25. Schepers RJ, Oyler JM, Joseph RE Jr (2003). Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem; 49:121–32.

26. Sergi M, Bafile E, Compagnone D (2009). Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MM. Anal Bioanal Chem, 393(2): 709-18.

27. Vearrier D, Curtis JA, Greenberg MI (2010). Biological testing for drugs of abuse. EXS; 100:489–517.

28. Wilson L, Jehanli A, Hand C (2007). Evaluation of a rapid oral fluid point-of-care test for MDMA. J Anal Toxicol, 31(2): 98-104.

29. Wood M, Laloup M, Fernandez M (2005). Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Science International; 150:227–38.

30. Wong RC, Tran M, Tung JK. (2005). Oral fluid drug tests: effects of adulterants and foodstuffs. Forensic Sci Int; 150:175–80.